nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—ABCC2—Sorafenib—thyroid cancer	0.228	0.388	CbGbCtD
Pranlukast—ABCC2—Doxorubicin—thyroid cancer	0.139	0.235	CbGbCtD
Pranlukast—CYP2C9—Sorafenib—thyroid cancer	0.0767	0.13	CbGbCtD
Pranlukast—CYP3A4—Vandetanib—thyroid cancer	0.074	0.126	CbGbCtD
Pranlukast—CYP3A4—Sorafenib—thyroid cancer	0.0446	0.0757	CbGbCtD
Pranlukast—CYP3A4—Doxorubicin—thyroid cancer	0.0271	0.0459	CbGbCtD
Pranlukast—NFKB1—saliva-secreting gland—thyroid cancer	0.00774	0.146	CbGeAlD
Pranlukast—MUC2—head—thyroid cancer	0.00735	0.139	CbGeAlD
Pranlukast—IL5—lymph node—thyroid cancer	0.0067	0.127	CbGeAlD
Pranlukast—NFKB1—trachea—thyroid cancer	0.00597	0.113	CbGeAlD
Pranlukast—TNF—lymph node—thyroid cancer	0.00515	0.0973	CbGeAlD
Pranlukast—NFKB1—thyroid gland—thyroid cancer	0.00473	0.0893	CbGeAlD
Pranlukast—NFKB1—head—thyroid cancer	0.00419	0.0792	CbGeAlD
Pranlukast—CYSLTR1—head—thyroid cancer	0.00412	0.0778	CbGeAlD
Pranlukast—NFKB1—lymph node—thyroid cancer	0.00294	0.0555	CbGeAlD
Pranlukast—CYSLTR1—lymph node—thyroid cancer	0.00288	0.0545	CbGeAlD
Pranlukast—ABCC2—lymph node—thyroid cancer	0.00115	0.0218	CbGeAlD
Pranlukast—NFKB1—Apoptosis Modulation and Signaling—TP53—thyroid cancer	0.000379	0.00106	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	0.000378	0.00106	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CALCB—thyroid cancer	0.000378	0.00106	CbGpPWpGaD
Pranlukast—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—AKT1—thyroid cancer	0.000376	0.00105	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—NRAS—thyroid cancer	0.000374	0.00105	CbGpPWpGaD
Pranlukast—NFKB1—Leptin signaling pathway—AKT1—thyroid cancer	0.000373	0.00104	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—TP53—thyroid cancer	0.000373	0.00104	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—KRAS—thyroid cancer	0.000372	0.00104	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.00037	0.00103	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—KRAS—thyroid cancer	0.000369	0.00103	CbGpPWpGaD
Pranlukast—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000368	0.00103	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—BRAF—thyroid cancer	0.000368	0.00103	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PTCH1—thyroid cancer	0.000366	0.00102	CbGpPWpGaD
Pranlukast—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000366	0.00102	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—HRAS—thyroid cancer	0.000366	0.00102	CbGpPWpGaD
Pranlukast—TNF—Cardiac Hypertrophic Response—AKT1—thyroid cancer	0.000365	0.00102	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—HRAS—thyroid cancer	0.000363	0.00101	CbGpPWpGaD
Pranlukast—IL5—Immune System—NRG1—thyroid cancer	0.000362	0.00101	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—HRAS—thyroid cancer	0.000359	0.001	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TRIM33—thyroid cancer	0.000359	0.001	CbGpPWpGaD
Pranlukast—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—thyroid cancer	0.000357	0.000997	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—CDK1—thyroid cancer	0.000357	0.000997	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—CCND1—thyroid cancer	0.000356	0.000995	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CDK1—thyroid cancer	0.000355	0.000991	CbGpPWpGaD
Pranlukast—TNF—Caspase Cascade in Apoptosis—AKT1—thyroid cancer	0.000354	0.00099	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000352	0.000983	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—AKT1—thyroid cancer	0.000348	0.000972	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Receptor Signaling Pathway—HRAS—thyroid cancer	0.000344	0.000962	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—PTEN—thyroid cancer	0.000342	0.000954	CbGpPWpGaD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—AKT1—thyroid cancer	0.000341	0.000953	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—AKT1—thyroid cancer	0.000341	0.000953	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SST—thyroid cancer	0.000335	0.000936	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—RXRA—thyroid cancer	0.000331	0.000925	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—TP53—thyroid cancer	0.000328	0.000916	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—PTEN—thyroid cancer	0.000326	0.000911	CbGpPWpGaD
Pranlukast—TNF—Alzheimers Disease—TP53—thyroid cancer	0.000323	0.000903	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—AKT1—thyroid cancer	0.000323	0.000902	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CALCA—thyroid cancer	0.000323	0.000901	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—KRAS—thyroid cancer	0.000322	0.0009	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000322	0.000899	CbGpPWpGaD
Pranlukast—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000321	0.000896	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000318	0.000888	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000318	0.000888	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000318	0.000888	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—AKT1—thyroid cancer	0.000317	0.000886	CbGpPWpGaD
Pranlukast—NFKB1—Corticotropin-releasing hormone—AKT1—thyroid cancer	0.000317	0.000886	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—HRAS—thyroid cancer	0.000316	0.000883	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—BRAF—thyroid cancer	0.000315	0.000881	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CDK1—thyroid cancer	0.000315	0.00088	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—HRAS—thyroid cancer	0.000314	0.000876	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000312	0.000873	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TSHR—thyroid cancer	0.000309	0.000864	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—NRAS—thyroid cancer	0.000309	0.000863	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—thyroid cancer	0.000308	0.00086	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000307	0.000857	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—NRAS—thyroid cancer	0.000305	0.000852	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PRKAR1A—thyroid cancer	0.000304	0.00085	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Receptor Signaling Pathway—AKT1—thyroid cancer	0.000304	0.000849	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—NRAS—thyroid cancer	0.000303	0.000847	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IFNA2—thyroid cancer	0.000303	0.000847	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—PTEN—thyroid cancer	0.000302	0.000843	CbGpPWpGaD
Pranlukast—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000298	0.000834	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—AKT1—thyroid cancer	0.000292	0.000816	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CDK1—thyroid cancer	0.000292	0.000816	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—NRAS—thyroid cancer	0.000291	0.000813	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MEN1—thyroid cancer	0.000291	0.000812	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.000284	0.000794	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—AKT1—thyroid cancer	0.000277	0.000774	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—HRAS—thyroid cancer	0.000274	0.000765	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—CDK1—thyroid cancer	0.000272	0.00076	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—TPR—thyroid cancer	0.000271	0.000757	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—NRAS—thyroid cancer	0.000269	0.000752	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—LGALS3—thyroid cancer	0.000269	0.000751	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000268	0.000749	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PRKAR1A—thyroid cancer	0.000266	0.000745	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—KRAS—thyroid cancer	0.000266	0.000743	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PTCH1—thyroid cancer	0.000263	0.000735	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—KRAS—thyroid cancer	0.000262	0.000733	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—KRAS—thyroid cancer	0.000261	0.000729	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—AKT1—thyroid cancer	0.00026	0.000726	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—AKT1—thyroid cancer	0.00026	0.000726	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000255	0.000714	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—NRG1—thyroid cancer	0.000253	0.000707	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.000253	0.000706	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—RXRA—thyroid cancer	0.000252	0.000705	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—HRAS—thyroid cancer	0.000251	0.000701	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—KRAS—thyroid cancer	0.00025	0.0007	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—NRG1—thyroid cancer	0.000243	0.000679	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000242	0.000677	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—AKT1—thyroid cancer	0.000242	0.000675	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SST—thyroid cancer	0.00024	0.000672	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—RXRA—thyroid cancer	0.00024	0.000672	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TCF7L1—thyroid cancer	0.000239	0.000668	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000238	0.000664	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TP53—thyroid cancer	0.000236	0.00066	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000236	0.000658	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TP53—thyroid cancer	0.000234	0.000655	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NRG1—thyroid cancer	0.000234	0.000655	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000234	0.000653	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TP53—thyroid cancer	0.000232	0.000648	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—KRAS—thyroid cancer	0.000232	0.000647	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CALCA—thyroid cancer	0.000231	0.000647	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—NRAS—thyroid cancer	0.000231	0.000646	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—AKT1—thyroid cancer	0.000228	0.000637	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—HRAS—thyroid cancer	0.000226	0.000632	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—HRAS—thyroid cancer	0.000223	0.000623	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—AKT1—thyroid cancer	0.000222	0.000622	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—PTEN—thyroid cancer	0.000222	0.000621	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—AKT1—thyroid cancer	0.000222	0.000619	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—TP53—thyroid cancer	0.000214	0.000598	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	0.000213	0.000596	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—HRAS—thyroid cancer	0.000213	0.000595	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TERT—thyroid cancer	0.00021	0.000588	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CDK1—thyroid cancer	0.00021	0.000586	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000209	0.000585	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—PPARG—thyroid cancer	0.000209	0.000584	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—NRAS—thyroid cancer	0.000202	0.000563	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HIF1A—thyroid cancer	0.000201	0.000562	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.0002	0.000558	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—AKT1—thyroid cancer	0.0002	0.000558	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—KRAS—thyroid cancer	0.000199	0.000556	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—NRAS—thyroid cancer	0.000198	0.000554	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—HRAS—thyroid cancer	0.000197	0.00055	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thyroid cancer	0.000197	0.00055	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—AKT1—thyroid cancer	0.000196	0.000547	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—thyroid cancer	0.000189	0.000527	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—AKT1—thyroid cancer	0.000188	0.000525	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CDK1—thyroid cancer	0.000184	0.000513	CbGpPWpGaD
Pranlukast—IL5—Immune System—PTEN—thyroid cancer	0.000182	0.000507	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000179	0.000502	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—NRAS—thyroid cancer	0.000177	0.000495	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000177	0.000494	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TP53—thyroid cancer	0.000177	0.000494	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MINPP1—thyroid cancer	0.000177	0.000493	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IFNA2—thyroid cancer	0.000176	0.000493	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TSHR—thyroid cancer	0.000175	0.000489	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—AKT1—thyroid cancer	0.000174	0.000486	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—AKT1—thyroid cancer	0.000174	0.000485	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—KRAS—thyroid cancer	0.000173	0.000485	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PRKAR1A—thyroid cancer	0.000172	0.000481	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—KRAS—thyroid cancer	0.000171	0.000477	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NRG1—thyroid cancer	0.000168	0.00047	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—BRAF—thyroid cancer	0.000167	0.000466	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MEN1—thyroid cancer	0.000165	0.00046	CbGpPWpGaD
Pranlukast—IL5—Immune System—NRAS—thyroid cancer	0.000162	0.000453	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—TP53—thyroid cancer	0.000162	0.000452	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.00016	0.000446	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—PPARG—thyroid cancer	0.000159	0.000445	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—AKT1—thyroid cancer	0.000159	0.000445	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—RXRA—thyroid cancer	0.000158	0.000443	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—KRAS—thyroid cancer	0.000153	0.000426	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TERT—thyroid cancer	0.000151	0.000422	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NDUFA13—thyroid cancer	0.00015	0.000419	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—AKT1—thyroid cancer	0.000149	0.000417	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PTCH1—thyroid cancer	0.000149	0.000416	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—HRAS—thyroid cancer	0.000147	0.000412	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—NRG1—thyroid cancer	0.000147	0.000412	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—HRAS—thyroid cancer	0.000145	0.000405	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HIF1A—thyroid cancer	0.000144	0.000404	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CHST14—thyroid cancer	0.000141	0.000394	CbGpPWpGaD
Pranlukast—IL5—Immune System—KRAS—thyroid cancer	0.000139	0.00039	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SST—thyroid cancer	0.000136	0.000381	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000135	0.000376	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CALCA—thyroid cancer	0.000131	0.000366	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HRAS—thyroid cancer	0.00013	0.000362	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—AKT1—thyroid cancer	0.000128	0.000358	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—NRAS—thyroid cancer	0.000128	0.000358	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—NRAS—thyroid cancer	0.000127	0.000356	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—PTEN—thyroid cancer	0.000127	0.000354	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—AKT1—thyroid cancer	0.000126	0.000352	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—PTEN—thyroid cancer	0.000122	0.00034	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCND1—thyroid cancer	0.000122	0.00034	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—BRAF—thyroid cancer	0.00012	0.000334	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CDK1—thyroid cancer	0.000119	0.000332	CbGpPWpGaD
Pranlukast—IL5—Immune System—HRAS—thyroid cancer	0.000119	0.000331	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PTEN—thyroid cancer	0.000117	0.000328	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MINPP1—thyroid cancer	0.000116	0.000325	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—AKT1—thyroid cancer	0.000115	0.00032	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HPGD—thyroid cancer	0.000114	0.000318	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—NRAS—thyroid cancer	0.000113	0.000316	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—KRAS—thyroid cancer	0.00011	0.000308	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—KRAS—thyroid cancer	0.00011	0.000306	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—NRAS—thyroid cancer	0.000109	0.000303	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NRAS—thyroid cancer	0.000105	0.000293	CbGpPWpGaD
Pranlukast—IL5—Immune System—AKT1—thyroid cancer	0.000105	0.000292	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NDUFA13—thyroid cancer	9.9e-05	0.000277	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—NRAS—thyroid cancer	9.75e-05	0.000272	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—KRAS—thyroid cancer	9.73e-05	0.000272	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NRG1—thyroid cancer	9.52e-05	0.000266	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—HRAS—thyroid cancer	9.36e-05	0.000262	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—KRAS—thyroid cancer	9.34e-05	0.000261	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HRAS—thyroid cancer	9.31e-05	0.00026	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CHST14—thyroid cancer	9.31e-05	0.00026	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	9.23e-05	0.000258	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—AKT1—thyroid cancer	9.05e-05	0.000253	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—KRAS—thyroid cancer	9.01e-05	0.000252	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCND1—thyroid cancer	8.73e-05	0.000244	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TERT—thyroid cancer	8.55e-05	0.000239	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PTEN—thyroid cancer	8.42e-05	0.000235	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—KRAS—thyroid cancer	8.39e-05	0.000234	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—HRAS—thyroid cancer	8.27e-05	0.000231	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—AKT1—thyroid cancer	8.27e-05	0.000231	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—AKT1—thyroid cancer	8.22e-05	0.00023	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HIF1A—thyroid cancer	8.18e-05	0.000229	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TP53—thyroid cancer	8.01e-05	0.000224	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—HRAS—thyroid cancer	7.94e-05	0.000222	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HRAS—thyroid cancer	7.66e-05	0.000214	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NRAS—thyroid cancer	7.52e-05	0.00021	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HPGD—thyroid cancer	7.5e-05	0.00021	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PTEN—thyroid cancer	7.38e-05	0.000206	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—AKT1—thyroid cancer	7.3e-05	0.000204	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—HRAS—thyroid cancer	7.13e-05	0.000199	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—AKT1—thyroid cancer	7.01e-05	0.000196	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—BRAF—thyroid cancer	6.77e-05	0.000189	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—AKT1—thyroid cancer	6.77e-05	0.000189	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—NRAS—thyroid cancer	6.58e-05	0.000184	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TPR—thyroid cancer	6.53e-05	0.000183	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—KRAS—thyroid cancer	6.47e-05	0.000181	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	6.43e-05	0.00018	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—AKT1—thyroid cancer	6.3e-05	0.000176	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.83e-05	0.000163	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TP53—thyroid cancer	5.75e-05	0.000161	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—KRAS—thyroid cancer	5.67e-05	0.000158	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HRAS—thyroid cancer	5.5e-05	0.000154	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCND1—thyroid cancer	4.94e-05	0.000138	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC5A5—thyroid cancer	4.89e-05	0.000137	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—AKT1—thyroid cancer	4.86e-05	0.000136	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HRAS—thyroid cancer	4.82e-05	0.000135	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PTEN—thyroid cancer	4.77e-05	0.000133	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.58e-05	0.000128	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TPR—thyroid cancer	4.31e-05	0.00012	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NRAS—thyroid cancer	4.26e-05	0.000119	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—AKT1—thyroid cancer	4.25e-05	0.000119	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	4.24e-05	0.000118	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—RXRA—thyroid cancer	4.11e-05	0.000115	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4e-05	0.000112	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—KRAS—thyroid cancer	3.66e-05	0.000102	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TP53—thyroid cancer	3.26e-05	9.1e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC5A5—thyroid cancer	3.23e-05	9.01e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HRAS—thyroid cancer	3.11e-05	8.7e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AKT1—thyroid cancer	2.75e-05	7.68e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—RXRA—thyroid cancer	2.71e-05	7.57e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PPARG—thyroid cancer	2.59e-05	7.25e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS2—thyroid cancer	2.04e-05	5.7e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTEN—thyroid cancer	1.78e-05	4.97e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PPARG—thyroid cancer	1.71e-05	4.78e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.35e-05	3.76e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTEN—thyroid cancer	1.17e-05	3.28e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—AKT1—thyroid cancer	1.03e-05	2.87e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AKT1—thyroid cancer	6.77e-06	1.89e-05	CbGpPWpGaD
